LPL and hyperkeratosis lenticularis perstans: Over a ten year period we have assembled a group of 102 patients from the lipid clinic, UKE with APOE2/2 genotype and hyperlipidemia giving us the opportunity to reinvestigate the role of these LPL SNPs in the development of Type III HLP in a larger, independently recruited group of patients as suggested by Sijbrands et al [5].